Pharma sector growth slowing down in US

Iqvia Consulting has reported that spending on prescription medicines was $457bn in the US in 2017, that is as little as +0.6% vs 2016, which means that growth has significantly slowed down in the sector as compared to the last few years, when growth rate was over +4%.